HETEROGENEITY OF NK AND NKT LYMPHOCYTE POPULATIONS IN HEALTHY DONORS

by D V. Tabakov, T. N. Zabotina, A. A. Borunova, I. O. Panchuk, O. V. Korotkova, Z. G. Kadagidze
Published 2017-08-01

Anti-cancer activity of сuraxin CBL0137 on the models of acute leukemia in vitro

by T. I. Fetisov, K. I. Kirsanov, A. A. Borunova, M. N. Zatsepina, E. A. Lesovaya, T. N. Zabotina, G. A. Belitsky, M. G. Yakubovskaya
Published 2019-12-01

DENDRITIC CELL-BASED VACCINE THERAPY IN PATIENTS WITH RENAL CELL CARCINOMA

by D. A. Nosov, A. A. Borunova, G. Z. Chkadua, V. B. Matveyev, E. S. Yakovleva, M. Yu. Fedyanin, Z. G. Kadagidze, T. N. Zabotina, S. A. Tyulyandin
Published 2014-07-01

DENDRITIC CELL-BASED VACCINE THERAPY IN PATIENTS WITH RENAL CELL CARCINOMA

by D. A. Nosov, A. A. Borunova, G. Z. Chkadua, V. B. Matveyev, E. S. Yakovleva, M. Yu. Fedyanin, Z. G. Kadagidze, T. N. Zabotina, S. A. Tyulyandin
Published 2014-07-01

Analysis of systemic immunity and inflammation in the prognosis of gastric adenocarcinoma

by G. G. Khakimova, T. N. Zabotina, A. A. Tryakin, A. A. Borunova, T. V. Davidova, A. E. Kalinin, Yu. V. Vakhabova, E. N. Zakharova, D. V. Tabakov
Published 2020-03-01

THE MAIN PARAMETERS OF CELLULAR IMMUNITY IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER: RELATIONSHIP WITH EFFICIENCY OF CHEMOTHERAPY

by A. I. Chertkova, E. G. Slavina, E. K. Shoua, L. G. Zhukova, M. A. Okruzhnova, V. A. Nurtdinova, A. A. Borunova, N. Т. Dzhgamadze, Z. G. Kadagidze
Published 2018-11-01

Activation of interferon-α signaling by resveratrol, genistein and quercetin

by O. A. Vlasova, A. A. Borunova, A. Safina, I. V. Smetanina, E. A. Lesovaya, G. A. Belitsky, T. N. Zabotina, K. Gurova, K. I. Kirsanov, M. G. Yakubovskaya
Published 2019-02-01